Authors: THURLIMANN B CASTIGLIONE M HSUSCHMITZ SF CAVALLI F BONNEFOI H FEY MF MORANT R LOHNERT T GOLDHIRSCH A

Citation: B. Thurlimann et al., FORMESTANE VERSUS MEGESTROL-ACETATE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS AFTER FAILURE OF TAMOXIFEN - A PHASE-III PROSPECTIVE RANDOMIZED CROSS-OVER TRIAL OF 2ND-LINE HORMONAL TREATMENT (SAKK-20 90)/, European journal of cancer, 33(7), 1997, pp. 1017-1024